3rd Quarter - Report

RED MAPLE CONSULTING, LLC for RESEARCH!AMERICA

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Federal funding of medical research, specifically for HR 5926 and S 3040, FY17 Labor-HHS appropriations bill (NIH, CDC, AHRQ) and HR 5054 and S 2956, FY 17 Agriculture appropriations bill (FDA) Federal funding for basic scientific research (NSF) in HR 5393 and S 2837, FY 17 Commerce, Justice-Science appropriations bill

LobbyistCovered position, as disclosed
PETE KIRKHAM —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5926 (114th), H.R. 5054 (114th), H.R. 5393 (114th)

Health Issues HCR

H.R. 6, 21st Century Cures Act, all provisions, and related draft S--- Senate "Innovations" package

LobbyistCovered position, as disclosed
PETE KIRKHAM —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.